“2014 Strategies for the UK Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key UK market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Research Beam Model: Research Beam Product ID: 15634 4300 USD New
2014 Strategies for the UK Microbiology Testing Market
 
 

2014 Strategies for the UK Microbiology Testing Market

  • Category : Diagnostic and Biotech
  • Published On : January   2014
  • Pages : 0
  • Publisher : VPGMarketResearch.com
 
 
 

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,300.



2014 Strategies for the UK Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key UK market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

 

Rationale



This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. 



Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. 



Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. 



Opportunities and Strategic Recommendations



- Emerging opportunities for new instrumentation,

  reagents kits, IT and other products with significant market 

  appeal during the next five years.



- Design criteria for decentralized testing products.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



Infectious Diseases Analyzed in the Report



AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, 

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, 

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, 

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, 

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.



Market Segmentation Analysis



- Sales and market shares of major suppliers 

  by individual test.



- Volume and sales forecasts for over 100 infectious disease 

   assays by individual test and market segment:



     ° Hospitals

     ° Blood Banks

     ° Commercial/Private Laboratories

     ° Public Health Laboratories



- Test volume estimates by method (molecular, serology/immunodiagnostics,

   culture/microscopy).



- Review of the market dynamics, trends,

  structure, size, growth and major suppliers.



Current and Emerging Products



- In-depth examination of over 100 major diseases, 

  including their etiology, current diagnostic tests, 

  vaccines, drugs and market needs.



- Review of major analyzers used for infectious disease

  testing, including their operating

  characteristics, features and selling prices.



Technology Review



- Assessment of molecular diagnostic, monoclonal antibody,

  immunoassay, and other technologies and their potential 

  applications for infectious disease testing.



- Global listings of companies developing or

  marketing infectious disease diagnostic products 

  by individual test.



Competitive Assessments



- Strategic assessments of major suppliers and 

  emerging market entrants, including their sales, product

  portfolios, marketing tactics, collaborative

  arrangements and new products in R&D.



Contains 978 pages and 159 tables


Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests


 1. AIDS

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 2. Adenovirus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

    d. Adeno-Associated Viruses(AAV)

 3. Aeromonas

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 4. Anthrax/Bacillus Anthracis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 5. Arboviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 6. Babesiosis

    a. Background

 7. Bacillary Epithelioid Angiomatosis (BEA) 

 And Other Bartonella (Rochalimaea)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 8. Blastocystis Hominis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 9. Brucella

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 10. Campylobacter

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 11. Candida

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 12. Chagas Disease

    a. Background

 13. Chancroid

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 14. Chlamydia

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 15. Clostridium Difficile

    a. Background

    b. Diagnostic Tests

    c. Drugs and Vaccines

 16. Coronaviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 17. Coxsackieviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 18. Creutzfeldt-Jakob’s Disease

    a. Background

    b. Diagnostic Tests

    c. Vaccines

 19. Cryptosporidium Parvum

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 20. Cyclospora Cayetanensis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 21. Cytomegalovirus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 22. Ebola Virus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 23. E. Coli

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 24. EchoVirus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 25. Encephalitis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 26. Enteroviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 27. Epstein-Barr Virus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 28. Giardia Lamblia

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 29. Gonorrhea

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 30. Granuloma Inguinale

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 31. Hantavirus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 32. Helicobacter Pylori

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 33. Hepatitis

    a. Background

    b. Hepatitis A

    c. Hepatitis B

    d. Hepatitis C

    e. Vaccines and Drugs

 34. Herpes Simplex Virus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 35. Human Herpes Virus-6 (HHV-6)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 36. Influenza Viruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 37. Legionella

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 38. Lyme Disease

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 39. Lymphogranuloma Venereum (LGV)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 40. Malaria

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 41. Measles (Rubeola)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 42. Meningitis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 43. Microsporidium

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 44. Mononucleosis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 45. Mumps

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 46. Mycoplasma

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 47. Papillomaviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 48. Parvovirus B19

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 49. Pneumonia

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 50. Polyomaviruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 51. Pseudomonas Aeruginosa

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 52. Rabies

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 53. Respiratory Syncytial Virus (RSV)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 54. RhinoViruses

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 55. RotaVirus (REOVIRUS)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 56. Rubella(MEASLES)

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 57. Salmonellosis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 58. Septicemia

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 59. Shigellosis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 60. Staphylococcus Aureus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 61. Streptococci

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 62. Syphilis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 63. Toxoplasmosis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 64. Trichomonas Vaginalis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 65. Tuberculosis

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 66. Vibrio

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 67. West Nile Virus

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 68. Yersina

    a. Background

    b. Diagnostic Tests

    c. Vaccines and Drugs

 B. Instrumentation Review of Leading Analyzers Marketed

 by Abbott, Beckman Coulter/Danaher, BioMerieux,

 Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,

 Wallac and Other Suppliers

C. Emerging Diagnostic Technologies 


 1. Molecular Diagnostics

 2. Monoclonal Antibodies

 3. Immunoassays

 4. Differential Light Scattering

 5. Information Technology

 6. Artificial Intelligence

 7. Liposomes

 8. Flow Cytometry

 9. Chromatography

 10. Diagnostic Imaging

 11. Gel Microdroplets

 12. Other

U.K.

 A. Executive Summary

 B. Business Environment

 C. Market Structure

 D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

 A. Instrumentation

 B. Reagent Kits and Test Systems/Panels

 C. Computers, Software and Automation

 D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies


 A. Internal Development

 B. Collaborative Arrangements

 C. University Contracts

 D. Distribution Strategies for Decentralized

 Testing Markets

 1. Marketing Approaches

 2. Product Complexity

 3. Customer Preference

 4. Established Suppliers

 5. Emerging Suppliers

 6. Major Types of Distributors

 7. Market Segmentation

Potential Market Entry Barriers and Risks

 A. Market Maturity

 B. Cost Containment

 C. Competition

 D. Technological Edge and Limitations

 E. Patent Protection

 F. Regulatory Constraints

 G. Decentralized Testing Market Challenges

Competitive Assessments




  • Abbott

  • Affymetrix 

  • Beckman Coulter/Danaher

  • Becton Dickinson

  • bioMerieux

  • Bio-Rad

  • Cepheid

  • Diamedix

  • DiaSorin

  • Eiken Chemical

  • Enzo Biochem

  • Fujirebio

  • Gen-Probe

  • Hologic

  • ID Biomedical

  • Innogenetics/Solvay

  • Kreatech

  • Life Technology

  • Lonza

  • Nanogen/Elitech

  • Novartis Diagnostics

  • Ortho-Clinical Diagnostics

  • Qiagen

  • Roche

  • Scienion

  • Sequenom

  • SeraCare

  • Siemens 

  • Takara Bio

  • Thermo Fisher 

  • Wallac

  • Wako



List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus

Tests

Major Companies Developing or Marketing Bartonella 

Tests

Major Companies Developing or Marketing 

Campylobacter Tests

Major Companies Developing or Marketing Candida 

Tests

Major Companies Developing or Marketing Chlamydia 

Tests

Major Companies Developing or Marketing Clostridium 

Tests

Major Companies Developing or Marketing Coronavirus 

Tests

Major Companies Developing or Marketing Cryptosporidium 

Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus 

Tests

Major Companies Developing or Marketing Enterovirus 

Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia 

Tests

Major Companies Developing or Marketing Gonorrhea 

Tests

Major Companies Developing or Marketing Hantavirus 

Tests

Major Companies Developing or Marketing Helicobacter 

Pylori Tests

Major Companies Developing or Marketing Hepatitis 

Tests

Major Companies Developing or Marketing Herpes 

Tests

Major Companies Developing or Marketing Influenza

Tests

Major Companies Developing or Marketing Legionella

Tests

Major Companies Developing or Marketing Lyme Disease

Tests

Major Companies Developing or Marketing Lymphogranuloma 

Tests

Major Companies Developing or Marketing Malaria 

Tests

Major Companies Developing or Marketing Measles 

Tests

Major Companies Developing or Marketing Meningitis

Tests

Major Companies Developing or Marketing Microsporidium 

Tests

Major Companies Developing or Marketing 

Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma

Tests

Major Companies Developing or Marketing Papilloma 

Virus Tests

Major Companies Developing or Marketing Parvovirus 

Tests

Major Companies Developing or Marketing Pneumonia

Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus

Tests

Major Companies Developing or Marketing Rubella 

Tests

Major Companies Developing or Marketing Salmonella 

Tests

Major Companies Developing or Marketing Septicemia

Tests

Major Companies Developing or Marketing Shigella

Tests

Major Companies Developing or Marketing Staphylococci 

Tests

Major Companies Developing or Marketing 

Streptococci Tests

Major Companies Developing or Marketing Syphilis

Tests

Major Companies Developing or Marketing Toxoplasmosis 

Tests

Major Companies Developing or Marketing Trichomonas 

Tests

Major Companies Developing or Marketing Tuberculosis 

Tests

Major Companies Developing or Marketing West Nile 

Tests

Major Companies Developing or Marketing Yersinia Tests

U.K. Summary Table

All Infectious Diseases Test Volume and Diagnostics 

Sales Forecast by Market Segment

U.K.

Laboratories Performing Infectious Disease Tests

by Market Segment

U.K.

Hospital Laboratories Performing Infectious Disease 

Tests by Bed Size

U.K.

Commercial/Private Laboratories Performing Infectious 

Disease Tests by Annual Test Volume

U.K.

All Market Segments Infectious Disease Test Volume Forecast

U.K.

Hospital Laboratories Infectious Disease Test Volume Forecast

U.K.

Blood Banks Infectious Disease Test Volume Forecast 

U.K.

Public Health Laboratories Infectious Disease Test 

Volume Forecast

U.K.

Commercial/Private Laboratories Infectious Disease 

Test Volume Forecast

U.K.

All Market Segments Infectious Disease Diagnostics 

Market Forecast

U.K.

Hospital Laboratories Infectious Disease Diagnostics 

Market Forecast

U.K.

Blood Banks Infectious Disease Diagnostics Market Forecast

U.K.

Public Health Laboratories Infectious Disease 

Diagnostics Market Forecast

U.K.

Commercial/Private Laboratories Infectious Disease 

Diagnostics Market Forecast

U.K.

HIV or HIV I/HIV II Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

HIVAg Test Volume and Diagnostics Sales Forecast by Market 

Segment

U.K.

Western Blot/Other Confirmatory Test Volume and 

Diagnostics Sales Forecast by Market Segment

U.K.

Adenovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Aeromonads

Test Volume and Diagnostics Sales Forecast by Market Segment

U.K. BEA Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Blastocystis Hominis Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

Campylobacter

Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Candida

Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Chancroid

Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Chlamydia Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Clostridium Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Coronavirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

CoxsackieVirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Cryptosporidium Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Cyclospora Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

CMV Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

E. Coli Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Echovirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Encephalitis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Enterovirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

EBV Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Giardia Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Gonorrhea Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Granuloma Inguinale Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

Helicobacter Pylori Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

HAV NAT Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

HBV NAT Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

HbsAg Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Hepatitis C Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Anti-HBc Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Anti-HBs Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Anti-HAV Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Hepatitis Delta Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

HBcAg Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

HBeAg Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Herpes Simplex I and II Test Volume and Diagnostics 

Sales Forecast by Market Segment

U.K.

Herpes Type VI Test Volume and Diagnostics 

Sales Forecast by Market Segment

U.K.

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics 

Sales Forecast by Market Segment

U.K.

Influenza Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Legionella Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Lyme Disease Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Lymphogranuloma Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Malaria Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Measles Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Meningitis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Microsporidium Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Mononucleosis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Mumps Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Mycoplasma Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Papilloma Virus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Parvovirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Pneumonia Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Polyomaviruses Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.K.

Pseudomonas Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Rabies Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

RSV Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Rhinovirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Rotavirus Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Rubella Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Salmonella Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Septicemia Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Shigella Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Staphylococci Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Streptococci Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Syphilis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Toxoplasmosis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Trichomonas Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Tuberculosis Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Vibrio Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

West Nile Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

Yersinia Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.K.

AIDS Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Campylobacter Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Candida Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Gonorrhea Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Hepatitis Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Hepatitis C Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Influenza Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Mycoplasma Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Pneumonia Testing Market Diagnostics Sales 

by Major Supplier

U.K.

RSV Testing Market Diagnostics Sales by Major Supplier

U.K.

Rubella Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Septicemia Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Shigella Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Streptococci Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Syphilis Testing Market Diagnostics Sales 

by Major Supplier

U.K.

Tuberculosis Testing Market Diagnostics Sales 

by Major Supplier


PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT